Description
MLN-2238 is a proteasome inhibitor that modulates miR33b, a tumor suppressor microRNA. MLN-2238 exhibits anticancer activity, downregulating Pim-1 activity in multiple myeloma cells.
Product Unit Size | Cost | Quantity | Stock |
---|
MLN-2238 is a proteasome inhibitor that modulates miR33b, a tumor suppressor microRNA. MLN-2238 exhibits anticancer activity, downregulating Pim-1 activity in multiple myeloma cells.
Cas No. | 1072833-77-2 |
---|---|
Purity | ≥95% |
Formula | C14H19BCl2N2O4 |
Formula Wt. | 361.03 |
IUPAC Name | [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid |
Synonym | Ixazomib |
Solubility | DMSO 72 mg/mL (199.42 mM) Ethanol 9 mg/mL (24.92 mM) Water Insoluble |
Appearance | White Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Tian Z, Zhao JJ, Tai YT, et al. Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells. Blood. 2012 Nov 8;120(19):3958-67. PMID: 22983447.
Precursor in the synthesis of hydroquinone, ant...
Nucleoside (cytidine) analog; DNMT inhibitor, p...
Notch inhibitor.
Alkylamine; histamine H1 antagonist, SERT and N...
Diaminoquinazoline derivative.
mTOR activator.
Endogenous peptide, connects A and B chains of ...
Synthetic cytokinin, plant growth regulator; fi...
Peptide, oxytocin analog; potential OXTR agonis...
ROCK inhibitor.
PLK4 inhibitor.
Calcitonin-family peptide, involved in vasodila...
Peptide, vSrc-induced cytokine.
Benzophenanthridine alkaloid found in various p...
EGFR inhibitor.
5-Fluorouracil derivative, fluorinated pyrimidi...
β-lactam; penicillin binding protein inhibitor...
Tricyclic antidepressant; potential D1/2 antago...
Casein kinase 2 inhibitor.
CHK1 inhibitor.